Fractional dose of scarce meningitis vaccine may be effective in outbreak control

December 5, 2008

One fifth of the standard dose of a commonly used meningitis vaccine may be as effective as using the full dose. This new finding should allow scarce vaccine resources to be stretched further, especially during epidemics in Africa.

In a study initiated by the Norwegian Institute of Public Health, together with Epicentre (the research arm of Doctors Without Borders/Médecins Sans Frontières), and Mbarara University of Science and Technology in Uganda, immune responses in patients receiving smaller doses of a meningitis vaccine were found to be comparable to a full dose.

In 2004, a randomized clinical trial of 750 healthy volunteers (2-19 years old) took place in Uganda. Their immune response, assessed by serum bactericidal activity (SBA), was measured for 1/5 and 1/10 doses compared to a full dose. SBA response and safety/tolerability using 1/5 dose were comparable to a full dose for three serogroups (A, Y, W135), but not a fourth (C).

The results have now been published in PLoS Neglected Tropical Diseases.

Source: Norwegian Institute of Public Health

Explore further: Booster dose of new meningitis vaccine may be beneficial

Related Stories

Booster dose of new meningitis vaccine may be beneficial

September 23, 2013

A study of 4CMenB, a new vaccine to protect against meningitis B bacteria (which can cause potentially fatal bacterial meningitis in children), shows that waning immunity induced by infant vaccination can be overcome by a ...

Meningitis epidemic kills more than 250 in Niger

May 4, 2015

A meningitis epidemic in poverty-stricken Niger has claimed 252 lives since January, a health official said Monday, warning the country was short of vaccines to fight the outbreak.

Niger needs 3.2 million meningitis vaccines: UN

February 17, 2016

Niger needs millions of doses of meningitis vaccines to ward off a possible epidemic after a spike that has seen dozens of cases reported since January, the United Nations said Wednesday.

Intranasal vaccine protects mice against West Nile infection

January 28, 2014

Researchers from Duke University have developed a nasal vaccine formulation that provides protective immunity against West Nile virus (WNV) infection in mice after only 2 doses. They present their findings at the 2014 American ...

Pioneering use of oral cholera vaccine during outbreak

October 17, 2013

In a report publishing October 17th, 2013 in PLOS Neglected Tropical Diseases, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and its scientific research arm, ...

Recommended for you

Zika in fetal brain tissue responds to a popular antibiotic

November 30, 2016

Working in the lab, UC San Francisco researchers have identified fetal brain tissue cells that are targeted by the Zika virus and determined that azithromycin, a common antibiotic regarded as safe for use during pregnancy, ...

Zika and glaucoma linked for first time in new study

November 30, 2016

A team of researchers in Brazil and at the Yale School of Public Health has published the first report demonstrating that the Zika virus can cause glaucoma in infants who were exposed to the virus during gestation.

Flu forecasts successful on neighborhood level

November 30, 2016

Scientists at Columbia University's Mailman School of Public Health developed a computer model to predict the onset, duration, and magnitude of influenza outbreaks for New York City boroughs and neighborhoods. They found ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.